Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd.
Your view on QNRX
Overview
What the company does, where it operates, and who runs it.
About Quoin Pharmaceuticals, Ltd.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Michael Myers
- Headquarters
- 42127 Pleasant Forest Court, Ashburn, VA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Michael Myers
- Headquarters
- 42127 Pleasant Forest Court, Ashburn, VA, US
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome.
It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Quoin Pharmaceuticals, Ltd., and the rating behind it. QNRX last traded at $6.79; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Quoin Pharmaceuticals, Ltd.. Starting points for Quoin Pharmaceuticals, Ltd.: EPS -$9.34, beta 1.66 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Quoin Pharmaceuticals, Ltd.. Quoin Pharmaceuticals, Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Quoin Pharmaceuticals, Ltd.. Trailing twelve-month EPS for Quoin Pharmaceuticals, Ltd. stands at -$9.34. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Quoin Pharmaceuticals, Ltd.. Quoin Pharmaceuticals, Ltd. has reported as a listed company since 2016. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Quoin Pharmaceuticals, Ltd. valued side by side against its closest peers. Quoin Pharmaceuticals, Ltd. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Quoin Pharmaceuticals, Ltd., and how their positions are changing. At a $13.6M market value, institutional positions materially move Quoin Pharmaceuticals, Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Quoin Pharmaceuticals, Ltd. executives and directors. Shares of Quoin Pharmaceuticals, Ltd. have traded between $5.01 and $48.30 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Quoin Pharmaceuticals, Ltd.. Quoin Pharmaceuticals, Ltd. is a $13.6M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Quoin Pharmaceuticals, Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Quoin Pharmaceuticals, Ltd.. Coverage tracks Quoin Pharmaceuticals, Ltd. within Biotechnology (Healthcare). Press releases and market coverage, newest first.